Fact-checked by Grok 2 weeks ago

Case fatality rate

The case fatality rate (CFR), also referred to as the case-fatality ratio, is an epidemiological measure that quantifies the proportion of individuals diagnosed with a specific or who die from it within a defined time frame, serving as an indicator of the disease's severity among detected cases. It is calculated by dividing the number of deaths attributed to the disease by the total number of confirmed cases, typically expressed as a : CFR = (deaths / confirmed cases) × 100. This metric is distinct from the infection fatality rate (IFR), which uses the total number of infections—including undetected or mild cases—as the denominator, often resulting in a lower estimate that better reflects overall . CFR plays a crucial role in , helping to assess the lethality of emerging infectious diseases, guide , and evaluate the effectiveness of interventions such as or treatments. For instance, during epidemics like , CFR estimates have varied widely across countries—ranging from 0.1% to over 25%—due to differences in testing capacity, healthcare access, and reporting standards. However, CFR can be misleading if case ascertainment is incomplete, as under-detection of mild cases inflates the rate, underscoring the need for complementary metrics like crude mortality rates (deaths per population) for cross-context comparisons. Factors influencing CFR include patient demographics (e.g., age and comorbidities), timeliness of and care, and viral or disease-specific characteristics, all of which must be considered for accurate interpretation.

Definitions and Basic Concepts

Definition of Case Fatality Rate

The case fatality rate (CFR) is a key epidemiological metric defined as the proportion of individuals diagnosed with a specific who die from that within a designated time period following diagnosis, usually presented as a to quantify disease severity among affected persons. This measure captures the lethality observed specifically within the cohort of confirmed cases, providing insight into the clinical outcome for those identified through diagnostic criteria rather than the overall exposure. The CFR emphasizes limited to diagnosed individuals, excluding undiagnosed or infections, which distinguishes it from broader incidence-based metrics in . By focusing solely on reported cases, it serves as a tool for evaluating the immediate threat posed by a to those seeking or receiving medical attention. The term "case fatality rate" emerged in early 20th-century within reporting. This usage reflected growing efforts to standardize measures of impact during widespread epidemics. The CFR inherently ranges from 0%, indicating no deaths among cases, to 100%, signifying universal fatality among diagnosed individuals, thereby highlighting variations in .

Terminology and Nomenclature

In , the term "case fatality rate" (CFR) refers to the proportion of individuals diagnosed with a specific who die from it, but the CFR is ambiguously used in to also denote "case fatality " or "case fatality risk." The distinction arises in usage: "case fatality proportion" (sometimes abbreviated CFP) emphasizes the measure as a simple of deaths to total cases without implying dynamics over time, while "case fatality " is employed when comparing across subgroups, such as groups or regions. This terminological overlap can lead to misinterpretation, prompting calls for more precise in peer-reviewed publications to avoid conflating static proportions with comparative analyses. Although widely termed a "rate," CFR is technically a proportion or rather than a true , as it does not incorporate a time dimension in its calculation, such as duration of illness or observation period. The has highlighted this inaccuracy, noting that the label "rate" misleadingly suggests temporal elements absent in the , which instead captures instantaneous among confirmed cases. Consequently, authoritative bodies like the Centers for Disease Control and Prevention advocate for alternatives like "case-fatality ratio" or "case-fatality proportion" to reflect its nature as a bounded probability rather than a dynamic incidence. The standard abbreviation CFR has been in consistent use since the early 20th century, distinguishing it from related but synonymous expressions like "" or "fatality rate," which are occasionally employed in clinical contexts to convey similar ideas of severity. In epidemiological , "" typically aligns directly with CFR as the proportion of fatal outcomes among cases, though it may appear in non-specialized literature without the precision of epidemiological qualifiers, potentially leading to overuse or loose application. This synonymy underscores the need for contextual clarity to prevent conflation with broader mortality indicators. The phrase "case fatality" first appeared around 1915–1920. By the mid-20th century, the full term "case fatality rate" solidified in usage, though debates over its precise labeling persist in contemporary epidemiology.

Calculation and Measurement

Formula and Computation

The case fatality rate (CFR) is computed as a proportion that quantifies the lethality of a disease among individuals who have been clinically diagnosed with it. The primary formula for CFR is given by: \text{CFR (\%)} = \left( \frac{\text{Number of deaths from the disease}}{\text{Number of confirmed cases of the disease}} \right) \times 100 This calculation relies on data aggregated over a defined observational period, typically aligned for both the numerator and denominator to ensure consistency. In the numerator, only deaths directly attributed to the disease among those diagnosed cases are included, excluding fatalities from other causes or among undiagnosed individuals. The denominator comprises solely the number of confirmed cases, which are individuals who meet established diagnostic criteria for the disease; this explicitly excludes undiagnosed, , or unreported infections to focus on observed clinical severity. Unresolved cases—such as ongoing infections where outcomes remain pending—are not counted in the numerator as deaths or recoveries, which can influence preliminary estimates. Preliminary CFR values are derived from surveillance data up to a specific reporting cutoff date, incorporating cumulative deaths and cases reported by that point; these estimates may evolve as additional cases resolve, potentially adjusting the rate upward or downward based on final outcomes. To compute CFR accurately during active outbreaks, data are drawn from standardized surveillance reports issued by health organizations, such as the (WHO), which compile verified case notifications and mortality attributions from national health systems.

Example Calculations

To illustrate the basic application of the case fatality rate (CFR) , consider a simple hypothetical scenario involving 200 confirmed cases of an illness, with 15 deaths reported. The calculation proceeds in steps: divide the number of deaths by the total number of confirmed cases to obtain the proportion (15 ÷ 200 = 0.075), then multiply by 100 to convert to a . \text{CFR} = \left( \frac{15}{200} \right) \times 100 = 7.5\% This yields a CFR of 7.5%, representing the proportion of confirmed cases that resulted in death. A more complex example arises when accounting for unresolved cases, where the denominator excludes ongoing cases to focus on resolved outcomes (deaths or recoveries). Suppose there are 100 confirmed cases: 10 deaths, 50 recoveries, and 40 ongoing. The resolved cases total 60 (10 deaths + 50 recoveries), so the CFR is calculated as the deaths divided by resolved cases, multiplied by 100. \text{CFR} = \left( \frac{10}{60} \right) \times 100 \approx 16.7\% This adjustment provides an estimate of fatality among cases with known outcomes, avoiding underestimation from including active cases. In real-world reporting, CFR is often computed using cumulative data—total deaths divided by total confirmed cases to date—which was a common practice in early pandemic tracking to monitor overall severity as information accrued.

Infection Fatality Rate

The Infection Fatality Rate (IFR) is the proportion of deaths among all individuals infected with a , encompassing both symptomatic and asymptomatic cases, as well as those that remain undiagnosed. This measure captures the true lethality of the infection across the entire infected population, rather than limiting analysis to reported cases. The formula for IFR is calculated as: \text{IFR (\%)} = \left( \frac{\text{Number of deaths from the disease}}{\text{Total number of infections}} \right) \times 100 In contrast to the (CFR), which focuses on deaths relative to confirmed cases, the IFR employs a larger denominator that includes undetected infections, resulting in the IFR always being less than or equal to the CFR; equality holds only if all infections are identified and reported. This distinction arises because many infections go unreported due to mild or absent symptoms, leading to significant underestimation of the total infection count and complicating direct IFR measurement. To address these estimation challenges, IFR is frequently derived from seroprevalence studies, which detect antibodies in samples to estimate the true extent of past infections in a . For instance, analyses using such methods have demonstrated that the IFR is substantially lower than the CFR, with a 2020 meta-analysis of global data yielding an IFR of 0.68% (95% CI: 0.53%–0.82%). Later studies, accounting for , variants, and improved , have reported lower IFRs, such as around 0.1% in some populations as of 2023–2024.

Other Mortality Rates

The crude mortality rate (CMR) measures the total number of deaths from all causes in a defined over a specific time period, typically expressed per 1,000 individuals. It provides a broad indicator of overall and is calculated by dividing the total deaths by the midyear and multiplying by 1,000. Unlike the case fatality rate (CFR), which focuses on deaths among confirmed cases of a specific , the CMR encompasses all causes of death and incorporates a temporal dimension, such as per year, to reflect ongoing mortality trends. Variations of the case fatality rate include age-adjusted and sex-specific CFRs, which account for demographic differences to enable more comparable analyses across populations. Age-adjusted CFRs apply age-specific fatality rates to a standard population distribution, eliminating biases from varying age structures between groups. Sex-specific CFRs, in contrast, restrict both the numerator (deaths) and denominator (cases) to one sex, revealing disparities such as higher rates among males in certain diseases. The CFR, including its adjusted forms, is particularly valuable for assessing disease severity among identified cases during outbreaks, where rapid tracking of lethality in affected individuals informs response strategies. In comparison, the CMR is used to evaluate the broader impact of mortality across an entire population, helping policymakers monitor overall vital statistics and needs.

Historical and Contemporary Examples

Historical Pandemics

The case fatality rate (CFR) has been a critical metric in understanding the lethality of historical pandemics, though early estimates were often derived from incomplete records and rudimentary diagnostic methods. One of the most devastating events was the in the , caused by , which swept through and between 1347 and 1351. Retrospective analyses of historical documents, such as parish records and chronicles, estimate the CFR at 30-60% among infected individuals, reflecting the plague's high mortality in the absence of effective treatments or isolation measures. These figures underscore the pandemic's profound impact, with population losses approaching 60% in some regions, though diagnostic limitations—such as reliance on symptomatic descriptions rather than microbiological confirmation—likely introduced variability in estimates. Smallpox, a endemic for millennia before its eradication, provides another stark example of high historical CFRs in unvaccinated populations. Prior to the , the variola major strain had a CFR of approximately 20-30% among those infected, with severe hemorrhagic forms approaching 100% fatality. This rate contributed to causing an estimated 300-500 million deaths globally in the alone, though pre-20th-century outbreaks in and the saw similar lethality, scarring survivors and decimating communities without immunity. The metric's application here highlights how CFR captured the disease's relentless toll before Edward Jenner's 1796 began reducing incidence and severity. The 1918 influenza pandemic, often called the , marked a transition toward more systematic CFR tracking amid disruptions. Caused by an H1N1 virus, it infected about one-third of the world's population and resulted in 50 million deaths globally, with an estimated CFR of 2-3% among reported cases—far higher than seasonal flu's typical 0.1%. Military camps and urban centers amplified spread, but wartime censorship and limited testing led to underreporting of mild cases, potentially inflating perceived lethality. Early CFR calculations for such events relied heavily on incomplete vital statistics and reports, often underestimating true rates due to unreported infections in remote areas. This began to change post-1950s with the establishment of formalized surveillance systems, such as the World Health Organization's global networks and the U.S. Centers for Disease Control and Prevention's expansions, enabling more accurate case ascertainment and CFR computation through standardized reporting.

Recent Outbreaks

The case fatality rate (CFR) for exhibited significant variation during the early stages of the . Globally, the CFR was estimated at approximately 2% in 2020 based on reported confirmed cases and deaths, reflecting initial challenges in testing and reporting. In , one of the hardest-hit countries early on, the initial CFR reached approximately 7.2% as of mid-March 2020, driven by overwhelmed healthcare systems and an older population demographic. As testing expanded and variants emerged, the global CFR declined progressively; for instance, the was associated with a CFR of about 0.7%, compared to 2.6% for the Alpha variant, due to higher transmissibility and milder severity in many cases. The 2014-2016 Ebola virus disease outbreak in West Africa remains one of the most significant recent epidemics, with a reported CFR of approximately 40% among confirmed cases. This outbreak, centered in Guinea, Liberia, and Sierra Leone, resulted in 28,600 cases and 11,325 deaths, highlighting the virus's high lethality in resource-limited settings despite international response efforts. The CFR was calculated from laboratory-confirmed cases, underscoring improvements in diagnostic capabilities compared to prior outbreaks, though access to care influenced outcomes. Middle East respiratory syndrome (MERS), first identified in 2012, has maintained a consistently high CFR of around 35-36% among reported cases through ongoing sporadic outbreaks, primarily in . As of 2025, 2,627 confirmed cases have been documented globally, with 947 deaths, reflecting the disease's severe impact on vulnerable populations such as those with comorbidities. The CFR remains stable due to the virus's limited human-to-human transmission but high fatality in hospitalized patients. By 2025, updated estimates of the CFR have incorporated data, revealing that reported figures underestimated the true burden; for example, global excess deaths in 2020 alone exceeded 3 million, suggesting adjusted CFRs closer to 3-4% when accounting for underreporting and indirect effects. These adjustments highlight long-term trends, with post-2020 CFRs stabilizing below 1% amid and variant evolution, though regional disparities persist. For context, the infection fatality rate (IFR) for is estimated at 0.5-1%, lower than early CFRs due to undetected mild cases.

Limitations and Influencing Factors

Challenges in Interpretation

Interpreting the case fatality rate (CFR) is complicated by methodological biases that can lead to systematic underestimation or overestimation of the true mortality risk. Incomplete case ascertainment, where mild or cases are not detected due to limited or testing, results in an artificially small denominator, thereby overestimating the CFR. For instance, during the respiratory syndrome () outbreak, the reported CFR of 36% was likely an overestimation because primarily captured severe cases, missing many mild infections. Conversely, delays in reporting deaths, often due to administrative processing or verification times, cause underestimation by reducing the numerator relative to the cases reported. Such reporting lags, which can span weeks, have been documented to artificially lower CFR estimates in real-time monitoring, as seen in analyses of U.S. provisional mortality data during the . A fundamental challenge arises from the CFR's failure to account for the time between case and potential , leading to volatile and biased estimates, particularly in the early stages of an outbreak. In acute infectious diseases, deaths do not occur immediately after case identification, so including recently reported cases in the denominator without adjusting for this incubation-to-death interval underestimates the CFR initially, as many cases remain unresolved and may contribute to future deaths. This time-lag bias is well-illustrated in analyses, where unadjusted CFR started low (e.g., below 1% in the first weeks) and rose as delayed deaths were recorded, highlighting the need for lag-adjusted methods to avoid misinterpretation. For or long-term diseases like cancer, the CFR is even less suitable, as deaths may occur years after , requiring extended observation periods that render short-term estimates unreliable and prone to substantial variability. Demographic variability further complicates CFR interpretation, as the rate differs markedly across subgroups, potentially misrepresenting overall if not stratified. Elderly individuals and those with comorbidities exhibit substantially higher CFRs; for example, during , the CFR exceeded 10% in adults over 80 years compared to under 1% in those under 40, driven by age-related vulnerabilities and underlying health conditions. Without adjustments for these factors, aggregate CFRs can obscure heterogeneous risks and lead to flawed decisions, emphasizing the importance of subgroup analyses in epidemiological assessments.

Factors Affecting CFR Estimates

The case fatality rate (CFR) for a is highly sensitive to the of healthcare systems, as to advanced treatments and critical directly influences outcomes. In settings with robust , such as adequate intensive care units (ICUs) and , severe cases can be managed more effectively, thereby reducing overall mortality among confirmed cases. For instance, during the , the availability of invasive in high-resource environments was associated with improved survival rates for critically ill s, contributing to lower CFR estimates compared to resource-limited areas where such interventions were scarce or delayed. Conversely, when healthcare systems are overwhelmed, exceeding leads to higher mortality, as seen in surges where delayed or absent critical elevated rates among hospitalized patients. Testing and surveillance practices significantly alter CFR estimates by affecting the denominator—the total number of confirmed cases. Early in outbreaks, often prioritizes severe or symptomatic individuals, resulting in a higher proportion of deaths relative to reported cases and thus an inflated CFR. As testing expands to include milder or infections through widespread screening and improved diagnostics, the pool of confirmed cases grows, lowering the apparent CFR since many additional cases do not result in death. This effect was evident in the response, where countries with higher testing coverage observed a progressive decline in CFR as milder cases were captured, highlighting how surveillance intensity biases initial severity assessments. Intrinsic disease characteristics, including virulence, viral variants, and incubation periods, further modulate CFR by influencing the likelihood and timing of severe outcomes. Virulence, defined as the disease's inherent capacity to cause death, is often quantified through CFR, with more virulent pathogens exhibiting higher rates due to greater tissue damage or immune evasion. Emerging variants can alter this dynamic; for example, SARS-CoV-2 variants of concern like Beta demonstrated higher CFRs (up to 4-5% in some analyses) compared to Omicron (around 0.5-1%), reflecting changes in transmissibility and pathogenicity that affect fatality. Incubation periods also play a role, as longer durations may allow for earlier detection and intervention, potentially reducing mortality risk, whereas shorter periods can lead to rapid progression and higher lethality in undiagnosed cases. Socioeconomic factors, particularly access to care, exacerbate CFR disparities across regions, often doubling rates in low-income areas due to barriers in timely and . In global health data through 2025, populations in low- and middle-income countries faced higher CFRs for infectious diseases like , driven by limited healthcare , , and economic constraints that delay seeking or receiving care. For example, age-adjusted mortality rates—closely tied to CFR—were nearly double in socioeconomically deprived neighborhoods compared to affluent ones, underscoring how amplifies fatality through reduced access to preventive and curative services. These disparities persist even after controlling for age and comorbidities, emphasizing the role of structural inequities in disease outcomes.

References

  1. [1]
    The Need to Use Mortality, and Not Case-Fatality, to Compare ... - NIH
    In epidemiology, the definition of case-fatality rate is “the proportion of cases of a specific condition that are fatal within a specified time”.
  2. [2]
    Estimating mortality from COVID-19
    Aug 4, 2020 · The second is case fatality ratio (CFR), which estimates this proportion of deaths among identified confirmed cases. To measure IFR accurately, ...
  3. [3]
    Case Fatality: Rate, Ratio, or Risk? : Epidemiology - Lippincott
    The probability of death among cases diagnosed with a disease is often used as a measure of disease severity. This quantity is usually estimated within a ...
  4. [4]
    Case Fatality Rate - an overview | ScienceDirect Topics
    Case fatality rate is defined as the proportion of incident patients who die from a disease or injury within a specified time window, providing insight into the ...
  5. [5]
    What is Case Fatality Rate (CFR)? - News-Medical
    Case Fatality Rate (CFR) measures the severity of disease by defining the total number of deaths as a proportion of reported cases at a specific time.
  6. [6]
    [PDF] Case fatality: rate, ratio or risk? - HKU Scholars Hub
    In the epidemiological literature the acronym CFR can denote case fatality rate, case fatality ratio or case fatality risk. Consistent with a living language, ...<|separator|>
  7. [7]
    Section 3: Mortality Frequency Measures - CDC Archive
    Case-fatality rate​​ The case-fatality rate is the proportion of persons with a particular condition (cases) who die from that condition. It is a measure of the ...
  8. [8]
    Case fatality rate | Radiology Reference Article - Radiopaedia.org
    24 abr 2020 · The epidemiological term, the case fatality rate (CFR) (also known as case fatality ratio, fatality rate or lethality rate) is a proportion ...
  9. [9]
    Basic Health Indicators - WikiLectures
    Lethality Rate ... Lethality = number of deaths / over number of sick with a specific disease (x100) It is also known as Case fatality rate. It is the proportion ...
  10. [10]
    CASE FATALITY RATE Definition & Meaning - Dictionary.com
    Word History and Origins. Origin of case fatality rate. First recorded in 1915–20. Did You Know? Tuxedo was given its name after gaining popularity among ...Missing: etymology epidemiology
  11. [11]
    None
    ### Case Fatality Rate Summary
  12. [12]
    Estimates of COVID-19's Fatality Rate Might Change. And ... - RAND
    Mar 11, 2020 · An important measure of the deadliness of a disease outbreak is the case-fatality rate (CFR). ... unresolved cases—individuals who have neither ...
  13. [13]
    Mortality Risk of COVID-19 - Our World in Data
    The IFR is the number of deaths from a disease divided by the total number of cases. If 10 people die of the disease, and 500 actually have it, then the IFR is ...Missing: equal | Show results with:equal
  14. [14]
    Case fatality rate vs. infection fatality rate
    The case fatality rate refers to the percentage of people who died from a specific disease compared to how many total people were officially diagnosed with the ...
  15. [15]
    Infection Fatality Rate (IFR) - Club Vita
    If every person who contracts the disease and every death attributable to the disease is known and recorded, then the CFR will equal the IFR. The CFR is ...<|control11|><|separator|>
  16. [16]
    [PDF] statnt06rv.pdf - CDC
    The annual crude death rate is defined as the total number of deaths over all ages divided by the midyear population. The crude death rate is then m = total ...
  17. [17]
    Crude death rate (per 1000 population)
    Definition: Number of deaths per 1000 population ; Method of measurement. Population data from the United Nations correspond to mid-year estimated values, ...Missing: formula | Show results with:formula
  18. [18]
    Age adjustment - Health, United States - CDC
    Jun 9, 2025 · Age-adjusted rates are computed using the direct method by applying age-specific rates in a population of interest to a standardized age distribution.
  19. [19]
    ESTIMATING MORTALITY RATES - NCBI - NIH
    In a crisis, one of the most important is the mortality rate. Epidemiologists conventionally use the crude mortality rate (CMR)—the number of deaths per 10,000 ...
  20. [20]
    The source of the Black Death in fourteenth-century central Eurasia
    Jun 15, 2022 · Estimated to have claimed the lives of up to 60% of the western Eurasian population over its eight-year course, the Black Death had a profound ...<|control11|><|separator|>
  21. [21]
    History of the Plague: An Ancient Pandemic for the Age of COVID-19
    Sep 24, 2020 · During the fourteenth century, the bubonic plague or Black Death killed more than one third of Europe or 25 million people.
  22. [22]
    History of Smallpox - CDC
    Oct 23, 2024 · Smallpox was a terrible disease. On average, 3 out of every 10 people who got it died. People who survived usually had scars, which were ...Early Control Efforts · Global Smallpox Eradication... · Last CasesMissing: fatality credible
  23. [23]
    Edward Jenner and the history of smallpox and vaccination - NIH
    The case-fatality rate varied from 20% to 60% and left most survivors with disfiguring scars.Missing: credible | Show results with:credible
  24. [24]
    Reassessing the Global Mortality Burden of the 1918 Influenza ... - NIH
    Mortality estimates of the 1918 influenza pandemic vary considerably, and recent estimates have suggested that there were 50 million to 100 million deaths ...
  25. [25]
    The 1918 Influenza Pandemic - virus
    The influenza virus had a profound virulence, with a mortality rate at 2.5% compared to the previous influenza epidemics, which were less than 0.1%. The death ...Missing: sources | Show results with:sources
  26. [26]
    What were the death tolls from pandemics in history?
    Dec 7, 2023 · The case-fatality rate of ... However, this figure has limitations: many countries lack surveillance and reporting of cholera cases.
  27. [27]
    Public Health Surveillance, 1961--2011 - CDC
    Oct 7, 2011 · During the 50 years since Langmuir published his concept of public health surveillance, developments in four areas have changed the field: 1) ...
  28. [28]
    The true death toll of COVID-19 estimating global excess mortality
    May 20, 2021 · Preliminary estimates suggest the total number of global deaths attributable to the COVID-19 pandemic in 2020 is at least 3 million, representing 1.2 million ...
  29. [29]
    COVID-19 Case-Fatality Rate and Characteristics of Patients Dying ...
    Mar 23, 2020 · The overall fatality rate of persons with confirmed COVID-19 in the Italian population, based on data up to March 17, was 7.2% (1625 deaths/22 512 cases).
  30. [30]
    Case fatality rates of COVID‐19 during epidemic periods of variants ...
    Jan 31, 2024 · The CFRs of COVID-19 varied across the epidemic periods of different VOCs, and disparities existed among continents.
  31. [31]
    Ebola outbreak 2014-2016 - West Africa
    This was the seventh outbreak of Ebola Virus Disease since its discovery. There were more cases and deaths in this outbreak than all others combined.Missing: CFR | Show results with:CFR
  32. [32]
    Outbreak History | Ebola - CDC
    It caused the 2014–2016 outbreak in West Africa, the largest Ebola disease outbreak to date, with more than 28,600 cases reported.Missing: CFR | Show results with:CFR
  33. [33]
    Middle East respiratory syndrome coronavirus (MERS-CoV)
    Approximately 35% of patients with MERS-CoV have died, but this may be an overestimate of the true mortality rate, as mild cases of MERS may be missed by ...
  34. [34]
    MERS outbreaks - WHO EMRO
    ... (MERS) were reported globally, with 947 associated deaths at a case-fatality ratio (CFR) of 36%. The majority of these cases were reported from Saudi Arabia ...Missing: present | Show results with:present
  35. [35]
    Mortality of Mechanically Ventilated COVID-19 Patients in ... - NIH
    However, exceeding the hospital capacity for critically ill COVID-19 patients was associated with higher mortality, which was consistent with the results of ...
  36. [36]
    Time-dependent risk of COVID-19 death with overwhelmed health ...
    Dec 12, 2022 · One of the most critical problems with COVID-19 was the surge in health-care demand, i.e. hospital caseload, which sometimes surpassed existing ...
  37. [37]
    Early Epidemiological Assessment of the Virulence of Emerging ...
    The case fatality ratio (CFR), the ratio of deaths from an infectious disease to the number of cases, provides an assessment of virulence.
  38. [38]
    Among SARS-CoV-2 variants, Beta had highest death rate, meta ...
    Feb 1, 2024 · The deadliest SARS-CoV-2 variant of concern (VOC) was Beta, followed by Gamma, Alpha, Delta, and Omicron, with variant-specific case-fatality rates (CFRs) ...Missing: incubation | Show results with:incubation
  39. [39]
    Association between Severity of MERS-CoV Infection and ... - CDC
    In the multivariable logistic regression model, we found that a longer incubation period was associated with a marginally reduced risk for death (odds ratio ...
  40. [40]
    COVID-19 case-fatality rate and demographic and socioeconomic ...
    Nov 3, 2020 · To investigate the influence of demographic and socioeconomic factors on the COVID-19 case-fatality rate (CFR) globally.
  41. [41]
    Social inequalities and COVID-19 mortality between neighborhoods ...
    Sep 28, 2023 · The age-adjusted death rate in the most deprived areas was almost double than in the least deprived areas, with an education-related relative ...